Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
Brendan A Daisley, Ryan M Chanyi, Kamilah Abdur-Rashid, Kait F Al, Shaeley Gibbons, John A Chmiel, Hannah Wilcox, Gregor Reid, Amanda Anderson, Malcolm Dewar, Shiva M Nair, Joseph Chin, Jeremy P Burton, Brendan A Daisley, Ryan M Chanyi, Kamilah Abdur-Rashid, Kait F Al, Shaeley Gibbons, John A Chmiel, Hannah Wilcox, Gregor Reid, Amanda Anderson, Malcolm Dewar, Shiva M Nair, Joseph Chin, Jeremy P Burton
Abstract
Abiraterone acetate (AA) is an inhibitor of androgen biosynthesis, though this cannot fully explain its efficacy against androgen-independent prostate cancer. Here, we demonstrate that androgen deprivation therapy depletes androgen-utilizing Corynebacterium spp. in prostate cancer patients and that oral AA further enriches for the health-associated commensal, Akkermansia muciniphila. Functional inferencing elucidates a coinciding increase in bacterial biosynthesis of vitamin K2 (an inhibitor of androgen dependent and independent tumor growth). These results are highly reproducible in a host-free gut model, excluding the possibility of immune involvement. Further investigation reveals that AA is metabolized by bacteria in vitro and that breakdown components selectively impact growth. We conclude that A. muciniphila is a key regulator of AA-mediated restructuring of microbial communities, and that this species may affect treatment response in castrate-resistant cohorts. Ongoing initiatives aimed at modulating the colonic microbiota of cancer patients may consider targeted delivery of poorly absorbed selective bacterial growth agents.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
- Matson V, et al. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients. Science. 2018;359:104–108. doi: 10.1126/science.aao3290.
- Routy B, et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science. 2018;359:91–97. doi: 10.1126/science.aan3706.
- Gopalakrishnan V, et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science. 2018;359:97–103. doi: 10.1126/science.aan4236.
- Plovier H, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 2017;23:107–113. doi: 10.1038/nm.4236.
- Dao MC, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426–436. doi: 10.1136/gutjnl-2014-308778.
- Acharya M, et al. A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects. Xenobiotica. 2013;43:379–389. doi: 10.3109/00498254.2012.721022.
- Shin J-H, et al. Serum level of sex steroid hormone is associated with diversity and profiles of human gut microbiome. Res. Microbiol. 2019;170:192–201. doi: 10.1016/j.resmic.2019.03.003.
- Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 2016;14:273. doi: 10.1038/nrmicro.2016.17.
- Sfanos KS, et al. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer Prostatic Dis. 2018;21:539–548. doi: 10.1038/s41391-018-0061-x.
- Decréau RA, Marson CM, Smith KE, Behan JM. Production of malodorous steroids from androsta-5,16-dienes and androsta-4,16-dienes by Corynebacteria and other human axillary bacteria. J. Steroid Biochem. Mol. Biol. 2003;87:327–336. doi: 10.1016/j.jsbmb.2003.09.005.
- Nixon A, Mallet AI, Jackman PJH, Gower DB. Testosterone metabolism by isolated human axillary Corynebacterium spp.: a gaschromatographic mass-spectrometric study. J. Steroid Biochem. 1986;24:887–892. doi: 10.1016/0022-4731(86)90450-4.
- Türk S, Mazzoli S, Štšepetova J, Kuznetsova J, Mändar R. Coryneform bacteria in human semen: inter-assay variability in species composition detection and biofilm production ability. Microb. Ecol. Health Dis. 2014;25:22701.
- Hughes DT, Sperandio V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat. Rev. Microbiol. 2008;6:111–120. doi: 10.1038/nrmicro1836.
- Dangi B, Oh T-J. Bacterial CYP154C8 catalyzes carbon-carbon bond cleavage in steroids. FEBS Lett. 2019;593:67–79. doi: 10.1002/1873-3468.13297.
- Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl. Environ. Microbiol. 2002;68:5186–5190. doi: 10.1128/AEM.68.10.5186-5190.2002.
- Belzer C, et al. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. mBio. 2017;8:e00770–17. doi: 10.1128/mBio.00770-17.
- Lopez-Siles M, et al. Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects. Front. Cell. Infect. Microbiol. 2018;8:e201800281. doi: 10.3389/fcimb.2018.00281.
- Berg, J. M., Tymoczko, J. L. & Stryer, L. The Glyoxylate Cycle Enables Plants and Bacteria to Grow on Acetate (W.H. Freeman, 2002).
- Smith JA, Nevin KP, Lovley DR. Syntrophic growth via quinone-mediated interspecies electron transfer. Front. Microbiol. 2015;6:121.
- Fenn K, et al. Quinones are growth factors for the human gut microbiota. Microbiome. 2017;5:161. doi: 10.1186/s40168-017-0380-5.
- Quinn L, et al. Helicobacter pylori antibiotic eradication coupled with a chemically defined diet in INS-GAS mice triggers dysbiosis and vitamin K deficiency resulting in gastric hemorrhage. Gut Microbes. 2020;11:820–841. doi: 10.1080/19490976.2019.1710092.
- Das P, Babaei P, Nielsen J. Metagenomic analysis of microbe-mediated vitamin metabolism in the human gut microbiome. BMC Genomics. 2019;20:208. doi: 10.1186/s12864-019-5591-7.
- Derrien M, Vaughan EE, Plugge CM, Vos WMde. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 2004;54:1469–1476. doi: 10.1099/ijs.0.02873-0.
- van der Beek CM, et al. Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clin. Sci. 2016;130:2073–2082. doi: 10.1042/CS20160263.
- Belzer C, de Vos WM. Microbes inside—from diversity to function: the case of Akkermansia. ISME J. 2012;6:1449–1458. doi: 10.1038/ismej.2012.6.
- Alard J, et al. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ. Microbiol. 2016;18:1484–1497. doi: 10.1111/1462-2920.13181.
- El Hage R, Hernandez-Sanabria E, Calatayud Arroyo M, Props R, Van de Wiele T. Propionate-producing consortium restores antibiotic-induced dysbiosis in a dynamic in vitro model of the human intestinal microbial ecosystem. Front. Microbiol. 2019;10:1206. doi: 10.3389/fmicb.2019.01206.
- Flynn JM, Phan C, Hunter RC. Genome-wide survey of Pseudomonas aeruginosa PA14 reveals a role for the glyoxylate pathway and extracellular proteases in the utilization of mucin. Infect. Immun. 2017;85:e00182–17. doi: 10.1128/IAI.00182-17.
- Ouwerkerk JP, et al. Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer. Appl. Environ. Microbiol. 2016;82:6983–6993. doi: 10.1128/AEM.01641-16.
- Espey MG. Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota. Free Radic. Biol. Med. 2013;55:130–140. doi: 10.1016/j.freeradbiomed.2012.10.554.
- Ravcheev DA, Thiele I. Genomic analysis of the human gut microbiome suggests novel enzymes involved in quinone biosynthesis. Front. Microbiol. 2016;7:128. doi: 10.3389/fmicb.2016.00128.
- Pacheco AR, et al. Fucose sensing regulates bacterial intestinal colonization. Nature. 2012;492:113–117. doi: 10.1038/nature11623.
- Ottman N, et al. Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle. Appl. Environ. Microbiol. 2017;83:e01014–e01017. doi: 10.1128/AEM.01014-17.
- Fusaro M, Gallieni M, Porta C, Nickolas TL, Khairallah P. Vitamin K effects in human health: new insights beyond bone and cardiovascular health. J. Nephrol. 2020;33:239–249. doi: 10.1007/s40620-019-00685-0.
- Dasari S, Samy ALPA, Kajdacsy-Balla A, Bosland MC, Munirathinam G. Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling. Food Chem. Toxicol. 2018;115:218–227. doi: 10.1016/j.fct.2018.02.018.
- Samykutty A, et al. Vitamin K2, a naturally occurring menaquinone, exerts therapeutic effects on both hormone-dependent and hormone-independent prostate cancer cells. Evid. Based Complement. Altern. Med. 2013;2013:287358. doi: 10.1155/2013/287358.
- Nimptsch K, Rohrmann S, Linseisen J. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg) Am. J. Clin. Nutr. 2008;87:985–992. doi: 10.1093/ajcn/87.4.985.
- Smolski M, Turo R, Whiteside S, Bromage S, Collins GN. Prevalence of prostatic calcification subtypes and association with prostate cancer. Urology. 2015;85:178–181. doi: 10.1016/j.urology.2014.09.026.
- Souza MC, et al. Biofilm formation and fibrinogen and fibronectin binding activities by Corynebacterium pseudodiphtheriticum invasive strains. Antonie Van Leeuwenhoek. 2015;107:1387–1399. doi: 10.1007/s10482-015-0433-3.
- Shrestha E, et al. Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J. Urol. 2018;199:161–171. doi: 10.1016/j.juro.2017.08.001.
- Cavarretta I, et al. The microbiome of the prostate tumor microenvironment. Eur. Urol. 2017;72:625–631. doi: 10.1016/j.eururo.2017.03.029.
- Burkovski A. Cell envelope of Corynebacteria: structure and influence on pathogenicity. ISRN Microbiol. 2013;2013:935736. doi: 10.1155/2013/935736.
- Ridaura VK, et al. Contextual control of skin immunity and inflammation by Corynebacterium. J. Exp. Med. 2018;215:785–799. doi: 10.1084/jem.20171079.
- Langowski JL, et al. IL-23 promotes tumour incidence and growth. Nature. 2006;442:461–465. doi: 10.1038/nature04808.
- Attard G, et al. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. J. Clin. Oncol. 2008;26:4563–4571. doi: 10.1200/JCO.2007.15.9749.
- Al KF, Bisanz JE, Gloor GB, Reid G, Burton JP. Evaluation of sampling and storage procedures on preserving the community structure of stool microbiota: a simple at-home toilet-paper collection method. J. Microbiol. Methods. 2018;144:117–121. doi: 10.1016/j.mimet.2017.11.014.
- McDonald JAK, et al. Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. J. Microbiol. Methods. 2013;95:167–174. doi: 10.1016/j.mimet.2013.08.008.
- Caporaso JG, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6:1621–1624. doi: 10.1038/ismej.2012.8.
- Callahan BJ, McMurdie PJ, Holmes SP. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis. ISME J. 2017;11:2639–2643. doi: 10.1038/ismej.2017.119.
- Bolyen E, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 2019;37:852–857. doi: 10.1038/s41587-019-0209-9.
- Fernandes AD, et al. Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome. 2014;2:15. doi: 10.1186/2049-2618-2-15.
- Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. Microbiome datasets are compositional: and this is not optional. Front. Microbiol. 2017;8:1–6. doi: 10.3389/fmicb.2017.02224.
- Halsey LG, Curran-Everett D, Vowler SL, Drummond GB. The fickle P value generates irreproducible results. Nat. Methods. 2015;12:179–185. doi: 10.1038/nmeth.3288.
- Faust K, et al. Microbial co-occurrence relationships in the human microbiome. PLoS Comput. Biol. 2012;8:e1002606. doi: 10.1371/journal.pcbi.1002606.
- Louca S, Doebeli M. Efficient comparative phylogenetics on large trees. Bioinformatics. 2018;34:1053–1055. doi: 10.1093/bioinformatics/btx701.
- Ye Y, Doak TG. A parsimony approach to biological pathway reconstruction/inference for genomes and metagenomes. PLoS Comput. Biol. 2009;5:e1000465. doi: 10.1371/journal.pcbi.1000465.
- Simhi E, van der Mei HC, Ron EZ, Rosenberg E, Busscher HJ. Effect of the adhesive antibiotic TA on adhesion and initial growth of E. coli on silicone rubber. FEMS Microbiol. Lett. 2000;192:97–100. doi: 10.1111/j.1574-6968.2000.tb09365.x.
- Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 2001;69:4572–4579. doi: 10.1128/IAI.69.7.4572-4579.2001.
- Sprouffske K, Wagner A. Growthcurver: an R package for obtaining interpretable metrics from microbial growth curves. BMC Bioinforma. 2016;17:172. doi: 10.1186/s12859-016-1016-7.
- Snyder, J. W., Atlas, R. M. & Atlas, R. M. Handbook of Media for Clinical Microbiology (CRC Press, 2006).
- Treitz C, Enjalbert B, Portais J-C, Letisse F, Tholey A. Differential quantitative proteome analysis of Escherichia coli grown on acetate versus glucose. Proteomics. 2016;16:2742–2746. doi: 10.1002/pmic.201600303.
Source: PubMed